UNIVERSITY OF MELBOURNE

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1853-01-01

Employees: 5K

Market Cap: -

Website: http://www.unimelb.edu.au

Clinical Trials

Prehabilitation for Patients Undergoing Lung Cancer Surgery

Not Applicable

Not yet recruiting

Conditions: Lung Cancer (NSCLC)

First Posted Date: 2024-12-04

Last Posted Date: 2024-12-04

Lead Sponsor: University of Melbourne

Target Recruit Count: 25

Registration Number: NCT06716437

Implementing Surgery School Prehabilitation Using Telehealth

Not Applicable

Not yet recruiting

Conditions: Lung Cancer
Colorectal Cancer
Oesophageal Cancer
Pancreas Cancer
Gastric Cancer

Interventions: Other: Usual Care
Behavioral: Individualised Inspiratory Muscle Training and Walking Program

First Posted Date: 2024-10-08

Last Posted Date: 2024-10-08

Lead Sponsor: University of Melbourne

Target Recruit Count: 545

Registration Number: NCT06631872

Locations: 🇦🇺
John Hunter Hospital, New Lambton Heights, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺
Launceston General Hospital, Launceston, Tasmania, Australia

and more 3 locations

Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

Not yet recruiting

Conditions: Stroke

Interventions: Other: Real-time electronic data input into REDCap

First Posted Date: 2024-07-30

Last Posted Date: 2024-07-30

Lead Sponsor: University of Melbourne

Target Recruit Count: 146

Registration Number: NCT06527261

Locations: 🇦🇺
Austin Health, Melbourne, Victoria, Australia

Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke

Not Applicable

Not yet recruiting

Conditions: Stroke
Ischemic Stroke

Interventions: Device: Magnetically enhanced diffusion

First Posted Date: 2024-07-11

Last Posted Date: 2024-07-11

Lead Sponsor: University of Melbourne

Target Recruit Count: 30

Registration Number: NCT06495671

Locations: 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺
John Hunter Hospital, Newcastle, New South Wales, Australia

and more 4 locations

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Not Applicable

Not yet recruiting

Conditions: Preterm Birth

Interventions: Drug: Erythromycin
Drug: Amoxicillin and Erythromycin
Drug: Azithromycin

First Posted Date: 2024-06-17

Last Posted Date: 2024-06-17

Lead Sponsor: University of Melbourne

Target Recruit Count: 100000

Registration Number: NCT06461429

Dose-Response Effects of Mindfulness Meditation

Not Applicable

Not yet recruiting

Conditions: Well-Being, Psychological
Depression

Interventions: Behavioral: Mindfulness meditation guided practice

First Posted Date: 2024-04-22

Last Posted Date: 2024-04-24

Lead Sponsor: University of Melbourne

Target Recruit Count: 860

Registration Number: NCT06378450

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

Phase 4

Recruiting

Conditions: Obesity
Knee Osteoarthritis
Osteoarthritis, Knee

Interventions: Drug: Placebo
Drug: Tirzepatide

First Posted Date: 2024-01-05

Last Posted Date: 2024-12-16

Lead Sponsor: University of Melbourne

Target Recruit Count: 352

Registration Number: NCT06191848

Locations: 🇦🇺
St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia

FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers

Not Applicable

Not yet recruiting

Conditions: Advanced Cancer

Interventions: Behavioral: FOCUSau

First Posted Date: 2023-10-13

Last Posted Date: 2023-10-13

Lead Sponsor: University of Melbourne

Target Recruit Count: 433

Registration Number: NCT06082128

Locations: 🇦🇺
Calvary Healthcare Kogarah, Kogarah, New South Wales, Australia
🇦🇺
Mater Health Service, Kangaroo Point, Queensland, Australia
🇦🇺
Northern Adelaide Palliative Service, Modbury, South Australia, Australia

and more 2 locations

Effect of Over-the-counter NSAIDS on Cough Reflex Sensitivity in Patients with Upper Respiratory Tract Infections

Early Phase 1

Completed

Conditions: Cough
Upper Respiratory Tract Infections

Interventions: Drug: Flurbiprofen Oral Lozenge
Drug: Difflam
Drug: Flurbiprofen 8.75 MG

First Posted Date: 2023-07-21

Last Posted Date: 2024-12-06

Lead Sponsor: University of Melbourne

Target Recruit Count: 101

Registration Number: NCT05955885

Locations: 🇦🇺
University of Melbourne, Carlton, Victoria, Australia

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Phase 2

Not yet recruiting

Conditions: Cerebrovascular Disorders
Ischemic Stroke, Acute
Brain Disorder
Central Nervous System Diseases

Interventions: Drug: Placebo
Drug: Intra-arterial tenecteplase injection at the completion of thrombectomy

First Posted Date: 2023-06-07

Last Posted Date: 2023-06-18

Lead Sponsor: University of Melbourne

Target Recruit Count: 462

Registration Number: NCT05892510

Locations: 🇦🇺
Alfred Hospital, Melbourne, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, Australia
🇦🇺
John Hunter Hospital, Newcastle, Australia

and more 9 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy